The situation began to escalate after Trump’s trade policy announcement on 5 April. The gold standard of business ...

MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.

While the pharmaceutical industry is currently exempt from US tariffs, there is an increased risk to the stability of the ...

Companies are developing myostatin inhibitors for GLP-1RA-related muscle loss, but some experts question their necessity.

CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.

Funding troubles and innovation responsibilities are falling more heavily on emerging biotechs under strain from US ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for BridgeBio Pharma’s ...

Biotech Biohaven has signed a non-dilutive funding deal with Oberland Capital as it awaits an FDA ruling on its ...